Less Ads, More Data, More Tools Register for FREE

Pin to quick picksConduit Hldg Regulatory News (CRE)

Share Price Information for Conduit Hldg (CRE)

Share Price is delayed by 15 minutes
Get Live Data
449.50    4.50 (1.01%)
Bid:
449.00
Ask:
450.00
Spread: 1.00 (0.223%)
Market Cap: £664.83m
CRE Live PriceLast checked at - London Stock Exchange

Intraday Conduit Hldg Share Chart

Pre-close Trading Statement

20 Apr 2009 07:00

RNS Number : 7777Q
Creston PLC
20 April 2009
 



 20 April 2009

Creston plc 

Pre-Close Trading Statement

Creston plc (LSE: CRE), the Insight and Communications Group, provides an update on trading prior to entering its close period in advance of the preliminary results for the year ended 31 March 2009.

In the 2009 financial year, the Company has performed ahead of consensus forecasts for revenue (achieving 4% year-on-year growth), EBIT, EBITDA, earnings per share and had a lower net debt position. 

This strong performance has been driven by an excellent new business performance that more than compensates for general market softness. Since the Interim Statement in November 2008, there have been a number of significant new business wins across the Group from both existing and new clients. These wins include Astellas, Boehringer Ingelheim, E-ON, GSK, Marie Curie Cancer Care, Panasonic, Spicers and Toyota. Net new business wins for the year will generate over £15 million in revenue (2008: £9 million). The Group continues to have a healthy pipeline of new business, especially in digital and on-line research. 

All acquired Group companies have completed their earn-out periods by 31 March 2009 and the final deferred consideration, which can now be finalised and is no longer contingent upon future profit levels, will be detailed in the preliminary announcement and will be settled in December 2009 and June 2010. 

At 31 March 2009, net debt was approximately £19 million having been reduced by over £12 million since September 2008, after a strong cash generating performance during the second half of the financial year. This reduction in net debt also follows the settlement of over £13 million deferred consideration in respect of DLKW.

The Group maintained tight management of its key performance indicators covering revenue and profit per head and operating profit margin. Consequently the Group ends the year with operating costs aligned to revenues forecast for the new financial year.

Creston plc expects to announce its preliminary results for the year ended 31 March 2009 on Tuesday, 23 June 2009.

-Ends- 

  

Enquiries: 

Creston plc

www.creston.com 

Don Elgie, Chief Executive

020 7930 9757

Barrie Brien, COO/CFO

Hogarth Partnership Limited

020 7357 9477

Chris Matthews / Fiona Noblet/ 

Anthony Arthur

Investec Bank (UK) Limited 

Erik Anderson/Ben Poynter

020 7597 5145

NOTES TO EDITORS:

Publication quality photographs are available through Hogarth on the numbers shown above.

About Creston plc

Since its inception in 2001, Creston has brought 10 leading brands under one roof in the UK, offering a host of blue-chip clients a range of services spanning advertising, public relations, digital marketing, market research, direct marketing and customer relationship marketing (CRM), among many others.

Creston is divided into two divisions: Insight, which encompasses those agencies engaged in understanding consumer behaviour, attitudes and needs, via research and evaluation; and Communications, which comprises agencies involved in influencing, shaping and changing consumer behaviours, attitudes and needs - this includes PR, advertising and marketing. Both divisions are entirely complementary.

Creston's share price is quoted on the London Stock Exchange under the symbol CRE and is published in the Financial Times, The Daily Telegraph, The Times and the London Evening Standard.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTGUUAPCUPBGCM
Date   Source Headline
27th Jun 20113:11 pmRNSHolding(s) in Company
23rd Jun 20113:59 pmRNSHolding(s) in Company
23rd Jun 201112:40 pmRNSHolding(s) in Company
21st Jun 20113:21 pmRNSHolding(s) in Company
21st Jun 20117:00 amRNSFinal Results
20th Jun 20115:46 pmRNSHolding(s) in Company
10th Jun 20117:00 amRNSDirectorate Change
10th May 20119:59 amRNSAnnual Information Update
10th May 20117:00 amRNSInvestor & Analyst Presentation
20th Apr 20117:00 amRNSTrading Statement
13th Apr 201112:14 pmRNSHolding(s) in Company
7th Apr 20114:02 pmRNSHolding(s) in Company
17th Feb 20112:28 pmRNSHolding(s) in Company
16th Feb 20112:21 pmRNSHolding(s) in Company
16th Feb 201112:39 pmRNSHolding(s) in Company
3rd Feb 20117:00 amRNSInterim Management Statement
5th Jan 20113:10 pmRNSNotice of Interim Management Statement
22nd Dec 20109:56 amRNSCompletion of Acquisition
15th Dec 201012:40 pmRNSResult of Meeting
30th Nov 20107:00 amRNSInterim Results
30th Nov 20107:00 amRNSAcquisition
8th Nov 20102:18 pmRNSHolding(s) in Company
19th Oct 20101:09 pmRNSHolding(s) in Company
19th Oct 20101:07 pmRNSHolding(s) in Company
11th Oct 201011:12 amRNSNotice of Interim Results
28th Sep 20108:00 amRNSCreation of E-Healthcare Start-Up
2nd Sep 201010:55 amRNSAGM Statement
26th Jul 20107:00 amRNSInterim Management Statement
14th Jul 20104:12 pmRNSDirector/PDMR Shareholding
14th Jul 201011:54 amRNSDisposal
13th Jul 20109:51 amRNSResult of General Meeting
28th Jun 20104:30 pmRNSPosting of Circular
28th Jun 201010:35 amRNSHolding(s) in Company
28th Jun 20107:01 amRNSDisposal
28th Jun 20107:00 amRNSFinal Results
26th May 20104:52 pmRNSHolding(s) in Company
26th May 20108:40 amRNSNotice of Results
21st May 201012:56 pmRNSHolding(s) in Company
13th May 20105:46 pmRNSHolding(s) in Company
26th Apr 20102:13 pmRNSHolding(s) in Company
22nd Apr 20103:05 pmRNSHolding(s) in Company
20th Apr 20107:00 amRNSPre-Close Trading Statement
6th Apr 20104:29 pmRNSDirector/PDMR Shareholding
6th Apr 20104:26 pmRNSDirector/PDMR Shareholding
23rd Mar 20104:50 pmRNSDirector/PDMR Shareholding
23rd Mar 20104:41 pmRNSDirector/PDMR Shareholding
17th Feb 20105:51 pmRNSHolding(s) in Company
3rd Feb 20107:00 amRNSInterim Management Statement
10th Dec 20097:33 amRNSDirector/PDMR Shareholding
2nd Dec 20097:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.